Product Overview
Rabizol D provides dual-action therapy for acid-related disorders by combining proton pump inhibition with enhanced gastrointestinal motility support.
Key Benefits
- Reduces gastric acid secretion
- Improves gastric emptying and reduces nausea
- Helps manage gastroesophageal reflux and related discomfort
Indications
- Gastroesophageal reflux disease (GERD)
- Peptic ulcer disease
- Symptomatic relief from nausea and vomiting
Marketed By
Vee Medi Biotech